A new photoacoustic flow cytometry was developed for real-time detection of circulating cells, nanoparticles, and contrast agents in vivo. Its capability, integrated with photothermal and optical clearing methods, was demonstrated using a near-infrared tunable laser to characterize the in vivo kinetics of Indocyanine Green alone and single cancer cells labeled with gold nanorods and Indocyanine Green in the vasculature of the mouse ear. In vivo applications are discussed, including selective nanophotothermolysis of metastatic squamous cells, label-free detection of melanoma cells, study of pharmokinetics, and immune response to apoptotic and necrotic cells, with potential translation to humans. The threshold sensitivity is estimated as one cancer cell in the background of 10 7 normal blood cells. © 2006 Optical Society of America OCIS codes: 170.0180, 170.1530, 170.6920, 170.1790 Flow cytometry (FC) is a well-established diagnostic method that revolutionized cell diagnostics in vitro. Nevertheless, the invasive extraction of cells from a living organism may introduce artifacts and make it impossible to conduct long-term monitoring of the cells in the complex natural environment. Recently, in vivo FC with fluorescent and photothermal (PT) techniques in the visible spectral range was successfully used for monitoring blood and cancer cells in the vasculature of the mouse ear and rat mesentery. [1] [2] [3] However, fluorescent labeling is still subject to cytotoxicity, while the label-free PT technique is currently limited to the transillumination (forward) mode. We introduce a new FC with near-IR photoacoustic (PA) detection of circulating cells in live animals in a backward model, either without labeling or with nontoxic gold labels.
Flow cytometry (FC) is a well-established diagnostic method that revolutionized cell diagnostics in vitro.
Nevertheless, the invasive extraction of cells from a living organism may introduce artifacts and make it impossible to conduct long-term monitoring of the cells in the complex natural environment. Recently, in vivo FC with fluorescent and photothermal (PT) techniques in the visible spectral range was successfully used for monitoring blood and cancer cells in the vasculature of the mouse ear and rat mesentery. [1] [2] [3] However, fluorescent labeling is still subject to cytotoxicity, while the label-free PT technique is currently limited to the transillumination (forward) mode. We introduce a new FC with near-IR photoacoustic (PA) detection of circulating cells in live animals in a backward model, either without labeling or with nontoxic gold labels.
In photoacoustic flow cytometry (PAFC), the individual cells in blood or lymph flow are irradiated with one or a few focused (or fiber-delivered) laser beams of different wavelengths; PA pulses from cells are detected with an ultrasonic transducer attached to the skin (Fig. 1) . The PAFC system was built on the platform of an Olympus BX51 microscope (Olympus America, Inc.) and a tunable optical parametric oscillator (OPO) pumped by a Nd:YAG laser (both from Lotis, Ltd., Minsk, Belarus). Laser pulses had an 8 ns pulse width, a repetition rate of 10 Hz, and a wavelength in the range of 420-2300 nm. PA signals from an ultrasonic transducer (Model XMS-310, Panametrics) and amplifier (Model 5662, Panametrics) were recorded with a Boxcar (Stanford Research Systems, Inc.) and a Tektronix TDS 3032B oscilloscope. The Boxcar technique provided averaging of PA signals from cells and time-resolved discrimination from background signals in skin and vessel walls. The signals from the oscilloscope were recorded with a digital video camera (JVC, Inc.). The PAFC was integrated with a photothermal flow cytometer 2,3 (PTFC). In the thermolens mode of the PTFC, laser-induced, temperature-dependent variations of the refractive index around cellular absorbing structures or contrast agents caused defocusing of a collinear He-Ne laser probe beam (Model 117A, Spectra-Physics, Inc.), which was detected with a photodiode (Model C5658, Hamamatsu Corp.) (Fig.  1) . Navigation of the pump beam on vessels was controlled with a Cascade 650 CCD camera (Roper Scientific, Inc.).
The capability of this new system was evaluated using a nude mouse ear model, which has a thin ͑ϳ270 m͒ and relatively transparent structure with a well-developed vasculature [ Fig. 2(a) ]. After standard anesthesia (ketamine/xylasine, 50/ 10 mg/ kg), the animal was placed on the microscopic stage after topical application of glycerol. Glycerol provided slight adherence of the ear to the slide, acoustic matching between the transducer and the ear, and reduction of scattered light, mainly from the epidermis. The last "optical clearing effect" significantly improved images of blood microvessels , bottom]. PAFC was used to detect circulating cancer cells (human squamous carcinoma cell line SQ20B) labeled with strongly near-IR absorbing gold nanorods (GNs), which were 15 nmϫ 52 nm in size and had a maximum absorption of nearly 840 nm. The GNs were synthesized with cetyltrimethylammonium bromide (CTAB). Then the GNs were centrifuged to eliminate the extra free CTAB in solution and were then incubated with cancer cells for 15 min at 37°C. To avoid the influence of immunogenicity on cell circulation, this was done without antibodies by using just electrical or endocytotic effects. The real-time accumulation of GN in the cells was monitored through an increase in PA or PT signals.
PT/PA spectroscopy at different pump laser wavelengths in vitro [ Fig. 4 
4 cancer cells labeled with GN into the mouse's circulatory system through the tail vein. Using PAFC, we found that the half-life of circulating these cells was ϳ15-20 min [ Fig. 4(b) ]. The capability of GN was compared with that of conventional contrast agents such as Indocyanine Green 4 (ICG). We first injected 3.5 mg/ kg of this dye alone into the mouse. Then, a similar procedure was performed with cancer cells stained with ICG (25 g / mL for 1 h at 37°C) [ Fig. 4(b) ]. The typical clearance time from the blood pool of ICG alone was approximately 10-20 min, which is in accordance with other data. 4 However, we observed the appearance of rare, strong PA signals (not previously described) above the continuous background signals from ICG in the blood [Fig. 4(c) ]. These signals lasted more than 1 h after the background signals from ICG had already disappeared. These fluctuations can be associated with the ability of individual reticulocytes (and probably neutrophils) to significantly uptake ICG directly in blood flow 5 and to circulate longer than pure ICG. Thus, PAFC with its high spatial (6-20 m, see above, and 0.5-1 m in imaging mode 2, 3 ), temporal (10 −4 -10 −1 s, depending on the pulse rate), and spectral (linewidth ഛ0.5 nm) resolution has great potential for studying the kinetics of dyes, drugs, and nanoparticles, in circulation.
At the same laser energy, linear PA signals from GN-labeled cancer cells were 5-7 times larger than the signals from cancer cells stained with ICG. This finding indicates the advantage of using GN labels in cases where the volume to be detected is small (i.e., within one cell). PA signals from single cells labeled with GN and from ICG alone in blood flow were comparable. This means that, despite a significantly higher absorption coefficient of GN than that of ICG, this advantage in local absorption may be partly lost because of spatial integration of PA/PT signals from limited numbers of strongly absorbing GNs within one cell. This is compared with the much larger number of less-absorbing dye molecules homogeneously distributed in the same or larger (i.e. within the laser beam) volumes. Cells stained with ICG were observed in circulation for a longer time ͑0.5-1.5 h͒ than cells labeled with GN [ Fig. 4(b) ]. This is probably due to the influence of the incompletely purified toxic component of CTAB, leading to faster clearance of partially nonviable cells in apoptotic or even necrotic states. Despite the fact that GN is not toxic, the preparation procedure requires further study. Also, one cannot exclude the possibility of partial GN detachment from labeled cells during their interaction with other cells and molecules in flow. Nevertheless, these data demonstrate the potential to monitor the clearance rate of cells in different states (e.g., apoptotic or necrotic) at a different immune status.
The PT thermolens method demonstrated advantages over the PA method in the sensitivity of labelfree detection of individual cells. The PA method provided higher sensitivity in detecting nanoparticles or their nanoclusters alone or in cells [ Fig. 3(d) ]. PT thermolens signals from the single nanoparticles were much weaker due to the influence of rapid heat diffusion (responsible for thermolens effects). According to our theoretical modeling, this effect is less important to PA signal generation, which is associated more with the initial stage of thermal expansion (or evaporating) of a thin layer of liquid around GN (we called it the spherical piston model). To detect GN, the pump-probe PT technique requires an extension of the thermal field or bubble around the GN above the diffraction limit, while the PA method with a nonoptical recording system is free of this optical limitation. Nevertheless, PT imaging provides higher resolution close to the diffraction limit, 2, 3 which is difficult to achieve with PA imaging because of the temporal limitation of transducers. On the other hand, an advantage of the PA technique is its backward mode (i.e., its laser and transducer are on one side), which is crucial for use on humans. PT and PA methods may beneficially supplement each other and, in combination, provide a powerful tool. For example, noninvasive PA diagnostics can be integrated with PT killing of metastatic or residual cancer cells, either static or in flow, by use of more powerful laser pulses triggered by PA signals from these cells. In particular, at 840 nm, strong absorption of GN provides complete killing of GN-labeled cancer cells ͑Ͼ99% ͒ with a very low photodamage threshold, currently 58 mJ/ cm 2 with the potential to go to 20 mJ/ cm 2 , without harmful effects for surrounding RBCs, for which the photodamage threshold is much higher: around 22 J / cm 2 at 840 nm (for leukocytes, 219 J / cm 2 ). The described technique is capable of detecting 10 Other applications of this tool in vivo may include (1) label-free detection of cells with differences in natural absorption (e.g., RBCs, WBCs, leukemia, and melanoma), (2) study of therapeutic impacts (e.g., radiation, drug, or laser) on individual flowing cells,
